Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
NCT06495983 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-07-11
Summary
This study is a observational study applying 24-hour microdialysis methodology to perform dynamic multisteroid adrenal hormone profiling of patients with suspected or confirmed PA. Simultaneous registration of blood pressure, tissue glucose, sleep pattern, activity level and food intake registration may be performed. The overall objective is to develop a novel, sensitive, fast and user-friendly diagnostic procedure for PA, using multimodal data capture including dynamic multisteroid hormone profiling from microdialysis fluid.
Conditions
- Mineralocorticoid Excess
- Primary Aldosteronism
- Hypercortisolism
Interventions
- DEVICE
-
dynamic microdialysis sampling
Included patients will perform 24-hour dynamic microdialysis sampling from subcutaneous tissue fluid of the lower abdomen, applying the U-Rhythm sampler. Simutaneous measurements of blood pressure, glucose, and registration of activity level, meals and sleep pattern during microdialysis sampling may be performed. Microdialysis sampling will be performed during various conditions: during daily life activities, during saline infusion suppression testing and during dexamethasone suppression testing. Repeated sampling may be performed post treatment.
Sponsors & Collaborators
-
University of Bergen
collaborator OTHER -
Haukeland University Hospital
lead OTHER
Principal Investigators
-
Marianne Aarda Grytaas, MD PhD · Haukeland University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- Norway
Study Locations
More Related Trials
-
HT-ENDO: A Multiomics-based Biomarker for the Diagnosis of Endocrine Hypertension: a Pragmatic, Diagnostic, Randomized, Outcome-based Trial
NCT06578975 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.
NCT00345215 ·Status: COMPLETED ·Phase: NA
-
Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism
NCT04991961 ·Status: COMPLETED
-
Primary Hyperaldosteronism and Ischemia-reperfusion Injury
NCT01978132 ·Status: COMPLETED ·Phase: NA
-
The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
NCT00438945 ·Status: COMPLETED ·Phase: PHASE4
-
Cortisol Secretion, Sensitivity and Activity and Hypertension
NCT05766085 ·Status: UNKNOWN
-
Effect of Renal Sympathetic Denervation on Resistant Hypertension and Cardiovascular Hemodynamic in Comparison to Intensive Medical Therapy Utilizing Impedance Cardiography
NCT01673516 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension
NCT00345124 ·Status: COMPLETED ·Phase: NA
-
Central Hemodynamics
NCT01837784 ·Status: UNKNOWN
-
Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors
NCT01630928 ·Status: COMPLETED ·Phase: NA
-
Neural Mechanism of Aldosterone-induced Insulin Resistance
NCT02102243 ·Status: WITHDRAWN ·Phase: PHASE4
-
Chongqing Primary Aldosteronism Study
NCT03224312 ·Status: RECRUITING
-
The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.
NCT00409903 ·Status: COMPLETED ·Phase: PHASE4
-
24-hour Urinary Aldosterone And Endocrine System In Obesity
NCT04354285 ·Status: COMPLETED
-
Renal Hemodynamics and Tubular Function in Patients With Obstructive Sleep Apnea and Healthy Controls
NCT00410085 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
NCT00004354 ·Status: COMPLETED
-
Long-term Blood Pressure Outcome After Unilateral Adrenalectomy for Primary Hyperaldosteronism
NCT03648294 ·Status: COMPLETED
-
Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease.
NCT01951196 ·Status: UNKNOWN
-
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
NCT00741585 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones
NCT01617551 ·Status: UNKNOWN ·Phase: NA
-
Reliable Hypertension Diagnosis Based on 24 ABPM
NCT03674918 ·Status: COMPLETED
-
Genetic Predisposition to High Blood Pressure
NCT07181213 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Aldosterone, Microvascular Function and Salt-sensitivity
NCT02068781 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcome of Patients With Resistant Hypertension Undergoing Renal Denervation
NCT04722159 ·Status: UNKNOWN
-
Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
NCT01850901 ·Status: COMPLETED ·Phase: PHASE3